Holger Stark

This inventor holds 6 USPTO granted patents and 2 EPO patents. Top assignees: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. , Fei Comapny, Max-Planck-Gesellschaft Zur Forderung Der Wissenschafte E.V.. Active years: 2016-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Holger Stark. Retrieved from https://idiyas.com/inventor/holger-stark-cfg2yfep

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 83.3

EPO Patents = 2 (Patent Applications = 9)

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 9(Granted Patents)

Company Filing History:

4 out of 1,334

Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V.

Max-Planck-Gesellschaft Zur Forderung Der Wissenschafte E.V.

patent

4. 1 out of 95

University of Antwerp

patents

where one patent can have more than one assignee

Years Active: 2016-2025

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12509682 - FATTY ACID SYNTHASE, INHIBITORS AND MODIFICATIONS THEREOF AND ITS USE (2025-12-30),

2. 11401301 - Method for the purification of biological macromolecular complexes (2022-08-02),

3. 11345724 - Proteasome inhibitors (2022-05-31),

4. 10829515 - Method for the purification of biological macromolecular complexes (2020-11-10),

5. 9412558 - High-resolution amplitude contrast imaging (2016-08-09),

6. 9366677 - Methods for analyzing biological macromolecular complexes and use thereof (2016-06-14),

Title: Holger Stark: Innovator in Biological Macromolecular Complexes

Introduction

Holger Stark is a prominent inventor based in Waake, Germany. He has made significant contributions to the field of biological macromolecular complexes, holding a total of 6 patents. His work focuses on innovative methods for purification and crystallization, which are crucial for advancements in personalized medicine.

Latest Patents

Stark's latest patents include a method for the purification of biological macromolecular complexes. This method does not involve chromatography steps, making it a unique approach in the field. Additionally, he has developed a method for crystallization of these complexes, which involves purification followed by crystallization in a reservoir solution containing a water-soluble polymer. Another notable patent relates to proteasome inhibitors, detailing a compound that targets the proteolytic site of a proteasome, which is essential for treating various diseases, including cancer and autoimmune disorders.

Career Highlights

Throughout his career, Holger Stark has worked with esteemed institutions such as the Max Planck Society for the Advancement of Science and the University of Antwerp. His research has significantly impacted the understanding and treatment of complex biological processes.

Collaborations

Stark has collaborated with notable colleagues, including Ashwin Chari and Jil Schrader, contributing to the advancement of research in his field.

Conclusion

Holger Stark's innovative work in the purification and crystallization of biological macromolecular complexes showcases his dedication to advancing science and medicine. His contributions are vital for the development of effective treatments for various diseases.

Profile summary based on public USPTO records.